EUVIMEDEUVIMED entdecken
Open Access

LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice

Uugantsetseg Munkhjargal, Daiju Fukuda, Juri Maeda, Tomoya Hara, Shintaro Okamoto, Oyunbileg Bavuu, Takayuki Yamamoto, Masataka Sata

Journal of Atherosclerosis and Thrombosis · 2024

DOI: 10.5551/jat.64468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Uugantsetseg Munkhjargal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences. Hauptthemen laut MEDLINE: Valsartan, Mice, Inbred C57BL, Aminobutyrates, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValsartanMice, Inbred C57BLAminobutyratesDiabetes Mellitus, ExperimentalEndothelium, VascularTetrazolesBiphenyl CompoundsAngiotensin Receptor AntagonistsHuman Umbilical Vein Endothelial CellsDrug CombinationsAnimalsMiceMaleHumansNeprilysin

Stichwörter der Autor:innen

DiabetesEndothelial dysfunctionNatriuretic peptideSacubitril/valsartan

Substanzen

Valsartansacubitril and valsartan sodium hydrate drug combinationAminobutyratesTetrazolesBiphenyl CompoundsAngiotensin Receptor AntagonistsDrug CombinationsNeprilysin

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences.
  • Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine.

Zitieren

APA

Munkhjargal, U., Fukuda, D., Maeda, J., Hara, T., Okamoto, S., Bavuu, O., Yamamoto, T., & Sata, M. (2024). LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64468

Vancouver

Munkhjargal U, Fukuda D, Maeda J, Hara T, Okamoto S, Bavuu O, et al. LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.64468

BibTeX
@article{Munkhjargal2024,
  author = {Munkhjargal, Uugantsetseg and Fukuda, Daiju and Maeda, Juri and Hara, Tomoya and Okamoto, Shintaro and Bavuu, Oyunbileg and Yamamoto, Takayuki and Sata, Masataka},
  title = {LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2024},
  doi = {10.5551/jat.64468}
}
Kostenlos starten →